Edition:
India

People: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Capital Market

3.93USD
20 Sep 2019
Change (% chg)

$0.21 (+5.65%)
Prev Close
$3.72
Open
$3.85
Day's High
$3.93
Day's Low
$3.85
Volume
2,294
Avg. Vol
16,148
52-wk High
$12.32
52-wk Low
$2.79

Shukla, Sanjay 

Dr. Sanjay Shukla, M.D., is President, Chief Executive Officer, Dr. Shukla served as our Chief Medical Officer from March 2016 to November 2017. From April 2015 to March 2016, Dr. Shukla worked in an advisory capacity for a number of companies, including as a consultant to aTyr from January 2016 to March 2016. Prior to that, from October 2012 to April 2015, Dr. Shukla served as Vice President and Global Head of Integrated Medical Services for Novartis, a biopharmaceutical company, where he led global medical affairs operations, with oversight for all pharma general medicines therapies, both inline and in development. Dr. Shukla served as Chief Executive Officer of RXMD, a clinical development consultancy that assisted in advancing proof of concept for early stage drug candidates, from April 2009 to September 2012. Prior to that, Dr. Shukla served in a variety of clinical development, data analytics and drug safety roles at Vifor Pharma, a biopharmaceutical company, and Aspreva Pharmaceuticals (acquired by Vifor Pharma). Dr. Shukla received his M.D. from Howard University College of Medicine and his Bachelors of Science in Microbiology and Master of Science in Epidemiology and Biostatistics from the University of Maryland.

Basic Compensation

Total Annual Compensation, USD 402,813
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,761,740
Fiscal Year Total, USD 2,164,560

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --